Core–shell hydrogel microspheres with sequential drug release and magnetothermal synergy for drug-resistant ovarian cancer

Ovarian cancer (OC) is one of the most fatal malignant tumors of the female reproductive system, and its high recurrence rate in advanced stages and drug resistance severely limit the efficacy of current treatment methods.